glp 1 agonist fda approval Comparing Ozempic, Wegovy and Other GLP-1 Drugs Pharmacovigilance Assessment of Compounded GLP-1

[138] In April 2025, the Trump Administration declined to finalize a proposal from the Biden Administration that would have required Medicare, Medicaid, and CHIP to broadly cover GLP-1s for weight loss

Purpose-built for physicians Racial discrepancies found in SGLT2, GLP-1 drug prescriptions in VA health system Prescription rates of SGLT2 inhibitors and GLP-1 receptor agonists among adults with type 2 diabetes in the Veterans Health Administration varied by race, with white patients most likely to receive these medications

Data Availability Statement No new data were created or analyzed in this study

The management of Type 1 diabetes in adults

Show details Table 6GLP-1 RA Products Approved in Canada GLP-1 = glucagon-like peptide-1

However, as more and more people take these medications, there appear to be other benefits, such as reducing ones risk of heart disease, stroke, kidney disease, and colon cancer